During the global COVID-19 pandemic, one of the key strategies to address the crisis was the implementation of mass vaccination campaigns. The distribution of the Pfizer COVID-19 vaccine posed a crucial challenge for the pharmaceutical industry: maintaining the vaccine at a constant temperature of -80 degrees. Any variation in this temperature could compromise the vaccine’s efficacy, negatively affecting public health. Given the severity and importance of the situation, Bidafarma, a leading pharmaceutical distribution company, faced this challenge and turned to Torsa’s technological innovation to ensure the product’s quality during storage and distribution of the Pfizer vaccine.
Bidafarma: Ensuring Quality in the Distribution of the Pfizer Vaccine
Bidafarma has been recognized for its commitment to excellence in the distribution of pharmaceutical products. With an extensive distribution network and a focus on innovation and quality, the company has played a crucial role in the fight against COVID-19. However, the complexity of keeping the Pfizer vaccine at a constant temperature of -80 degrees during storage and transportation posed a significant challenge. Even a brief temperature fluctuation could result in the loss of vaccine efficacy, putting public health at risk and wasting valuable resources.
The challenge of temperature monitoring in pharmaceutical logistics
The need for continuous and precise temperature monitoring in the distribution of the Pfizer vaccine was not merely a matter of regulatory compliance but a public health issue. Exposure to temperatures outside the specified range could lead to:
- The inactivation of the vaccine’s active ingredient.
- The inability to ensure effective immunization.
- The loss of confidence in the vaccination process.
- The need to discard entire vaccine batches, resulting in economic losses and delays in the vaccination campaign.
The solution: Torsa’s Borea System
To overcome this challenge, Bidafarma implemented Torsa’s Borea System, a comprehensive real-time temperature monitoring solution. This system not only provides continuous temperature control but also ensures full traceability of the product from storage to final delivery. The main benefits of the Borea System include:
Real-time temperature monitoring: thanks to an IoT sensor network, the system can constantly monitor the temperature and detect any deviation instantly. This real-time monitoring capability allows Bidafarma to react quickly to any temperature changes, minimizing the risk of vaccine inactivation.
- Complete traceability: with the .torsacloud business intelligence platform, Bidafarma can track every stage of the process, ensuring the product’s integrity.
- Configurable alerts: the system generates customizable alerts that allow operators to respond quickly to any anomaly.
Report generation: the Borea system also facilitates the creation of detailed reports that provide a complete record of all temperature measurements and critical events. These reports are essential for regulatory compliance, conducting internal audits, and optimising logistical processes.
Benefits of Torsa’s Borea System: efficiency and security in the cold chain
The implementation of Torsa’s Borea system by Bidafarma is an exemplary case of how technology can solve complex problems in process monitoring. Through real-time temperature monitoring and an IoT sensor network, Bidafarma has been able to ensure the quality and safety of the Pfizer vaccine, protecting public health, optimising logistics operations, and saving costs. If your company is also facing similar challenges and looking to optimise its logistics operations, we invite you to discover how Torsa’s Borea system can improve your processes, save costs, and ensure the quality of your products.
